scispace - formally typeset
M

Michael Snyder

Researcher at Stanford University

Publications -  938
Citations -  150929

Michael Snyder is an academic researcher from Stanford University. The author has contributed to research in topics: Gene & Genome. The author has an hindex of 169, co-authored 840 publications receiving 130225 citations. Previous affiliations of Michael Snyder include Wyss Institute for Biologically Inspired Engineering & Public Health Research Institute.

Papers
More filters
Journal ArticleDOI

Distinct genomic aberrations associated with ERG rearranged prostate cancer.

TL;DR: This study performs genome‐wide profiling of 49 primary prostate cancers and identifies 20 recurrent chromosomal copy number aberrations, mainly occurring as genomic losses, and demonstrates that high‐resolution tiling arrays can be used to pin‐point breakpoints leading to fusion events.
Journal ArticleDOI

Systematic identification of silencers in human cells.

TL;DR: It is found that silencers are widely distributed and may function in a tissue-specific fashion and probably contributes substantially to the regulation of gene expression and human biology.
Journal ArticleDOI

Nuclear dot antigens may specify transcriptional domains in the nucleus.

TL;DR: It is suggested that nuclear dot antigens may participate in the activation of transcription of specific regions of the genome in yeast and primate cells.
Journal ArticleDOI

Systematic prediction and validation of breakpoints associated with copy-number variants in the human genome.

TL;DR: An iterative, “active” approach to initially scoring with a preliminary model, performing targeted validations, retraining the model, and then rescoring, and a flexible parameterization system that intuitively collapses from a full model of 2,503 parameters to a core one of only 10 enable the study of CNV population frequencies.
Journal ArticleDOI

Systems biology: personalized medicine for the future?

TL;DR: The efforts of systems biology in personalized medicine in the past 2 years are reviewed, and achievements and concerns are discussed, as well as highlights and hurdles for future personalized health care.